FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
Deutsche Bank upgraded Hospira (NYSE: HSP) from Hold to Buy with a price target of $61.00 (from $53.00). The change follows Q2 results. Analyst Gregg Gilbert said improvement in revenue, gross margin, and cash flow were hard to ignore.
"Following todays 2Q results and management commentary, which support the positive tone struck in 1Q, we are more confident that... More


